Davis Hugh M. bought ACRS
February 2, 2026 · Form 4 insider transaction
Davis Hugh M. bought 336,300 shares of Aclaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
336,300
Price
$0.00
Total value
N/A
InsiderDavis Hugh M.
RoleOfficer, Director
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 6, 2026
Shares owned after336,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.